Perfil del autor: Soto Moreno, Alfonso Manuel
Datos institucionales
Nombre | Soto Moreno, Alfonso Manuel |
Departamento | Medicina |
Área de conocimiento | Medicina |
Categoría profesional | Profesor Asociado CIS |
Correo electrónico | Solicitar |
Estadísticas
-
Nº publicaciones
14
-
Nº visitas
1032
-
Nº descargas
1617
Publicaciones |
---|
Artículo
Postoperative water and electrolyte disturbances after extended endoscopic endonasal transsphenoidal surgery
(Frontiers Media, 2022)
Introduction: Water and electrolyte disturbances are common after pituitary surgery and can generally be classified into ... |
Artículo
Cardiometabolic and Nutritional Morbidities of a Large, Adult, PKU Cohort from Andalusia
(MDPI, 2022)
The establishment of national neonatal screening systems has resulted in improved quality of life and life expectancy in ... |
Artículo
Epigenetic and post-transcriptional regulation of somatostatin receptor subtype 5 (SST5) in pituitary and pancreatic neuroendocrine tumors
(WILEY, 2022)
Somatostatin receptor subtype 5 (SST5) is an emerging biomarker and actionable target in pituitary (PitNETs) and pancreatic ... |
Artículo
Sex Hormone Receptor Expression in Craniopharyngiomas and Association with Tumor Aggressiveness Characteristics
(MDPI, 2022)
Craniopharyngiomas (CPs) are rare tumors of the sellar and suprasellar regions of embryonic origin. The primary treatment ... |
Artículo
Description of a Cohort of Type 1 Diabetes Patients: Analysis of Comorbidities, Prevalence of Complications and Risk of Hypoglycemia
(MDPI, 2022)
Background: Despite major medical advances, Type 1 Diabetes (T1D) patients still have greater morbimortality than the ... |
Artículo
Description of characteristics and outcomes of a cohort of patients with severe and enduring eating disorders (SE-ED)
(BMC, 2021)
Objective: To describe the characteristics of the patients, as well as the treatment outcomes for the people treated in ... |
Artículo
A silent corticotroph pituitary carcinoma: lessons from an exceptional case
(Frontiers Research Foundation, 2021)
Nowadays, neither imaging nor pathology evaluation can accurately predict the aggressiveness or treatment resistance of ... |
Artículo
Quantitative Analysis of Somatostatin and Dopamine Receptors Gene Expression Levels in Non-Functioning Pituitary Tumors and Association with Clinical and Molecular Aggressiveness Features
(MDPI, 2020)
The primary treatment for non-functioning pituitary tumors (NFPTs) is surgery, but it is often unsuccessful. Previous ... |
Artículo
E-cadherin expression is associated with somatostatin analogue response in acromegaly
(Wiley-Blackwell, 2019)
Acromegaly is a rare disease resulting from hypersecretion of growth hormone (GH) and insulin‐like growth factor 1 (IGF1) ... |
Artículo
Neurocognitive Function in Acromegaly after Surgical Resection of GH-Secreting Adenoma versus Naïve Acromegaly
(Elsevier, 2013)
Patients with active untreated acromegaly show mild to moderate neurocognitive disorders that are associated to chronic ... |
Artículo
Budget impact of using midnight salivary cortisol in the diagnosis of hypercortisolism
(Elsevier, 2011)
Background A single midnight serum cortisol (MSC) test has been reported to possess the best sensitivity and specificity ... |
Tesis Doctoral
Marcadores de riesgo cardiovascular y aterosclerosis prematura en pacientes con deficiencia de hormona de crecimiento del adulto
(2010)
El hipopipuitarismo se define como el síndrome clínico que se produce tras la deficiencia de producción hormonal de la ... |
Artículo
Evidence of Cognitive and Neurophysiological Impairment in Patients with Untreated Naive Acromegaly
(Oxford University Press, 2010)
Context: Recent studies have suggested that long-term exposure to high levels of GH and IGF-I affect brain and cognitive ... |
Tesis Doctoral
Evaluación de la amplificación del ARNM de la tiroglobulina en sangre como método para la identificación de recidivas en el cáncer diferenciado de tiroides
(2002)
El CDT, que incluye al Carcinoma Papilar y al Carcinoma Folicular de tiroides, supone más del 90% de los tumores tiroideos, ... |